Edgemoor Investment Advisors, Inc. Novartis Ag Transaction History

Edgemoor Investment Advisors, Inc.

  • $1.07 Billion
  • Q2 2024

A detailed history of Edgemoor Investment Advisors, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Edgemoor Investment Advisors, Inc. holds 129,969 shares of NVS stock, worth $14.4 Million. This represents 1.3% of its overall portfolio holdings.

Number of Shares
129,969
Previous 133,877 2.92%
Holding current value
$14.4 Million
Previous $12.9 Million 6.85%
% of portfolio
1.3%
Previous 1.24%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024
SELL
$92.57 - $107.37 $361,763 - $419,601
-3,908 Reduced 2.92%
129,969 $13.8 Million
Q1 2024

May 09, 2024
SELL
$95.27 - $108.47 $126,613 - $144,156
-1,329 Reduced 0.98%
133,877 $12.9 Million
Q4 2023

Feb 07, 2024
SELL
$92.27 - $101.54 $169,130 - $186,122
-1,833 Reduced 1.34%
135,206 $13.7 Million
Q3 2023

Nov 09, 2023
SELL
$94.73 - $105.13 $175,534 - $194,805
-1,853 Reduced 1.33%
137,039 $14 Million
Q2 2023

Aug 09, 2023
SELL
$92.52 - $104.91 $165,888 - $188,103
-1,793 Reduced 1.27%
138,892 $14 Million
Q1 2023

May 09, 2023
SELL
$80.03 - $92.81 $36,893 - $42,785
-461 Reduced 0.33%
140,685 $12.9 Million
Q4 2022

Feb 07, 2023
SELL
$75.55 - $92.52 $26,820 - $32,844
-355 Reduced 0.25%
141,146 $12.8 Million
Q3 2022

Nov 08, 2022
SELL
$74.61 - $87.26 $142,505 - $166,666
-1,910 Reduced 1.33%
141,501 $10.8 Million
Q2 2022

Aug 04, 2022
SELL
$80.52 - $93.75 $306,459 - $356,812
-3,806 Reduced 2.59%
143,411 $12.1 Million
Q1 2022

May 12, 2022
SELL
$80.11 - $90.62 $254,990 - $288,443
-3,183 Reduced 2.12%
147,217 $12.9 Million
Q4 2021

Feb 09, 2022
SELL
$79.7 - $88.13 $193,910 - $214,420
-2,433 Reduced 1.59%
150,400 $13.2 Million
Q3 2021

Nov 02, 2021
SELL
$81.78 - $95.14 $3.01 Million - $3.5 Million
-36,800 Reduced 19.41%
152,833 $12.5 Million
Q2 2021

Aug 11, 2021
SELL
$85.24 - $94.15 $47,052 - $51,970
-552 Reduced 0.29%
189,633 $17.3 Million
Q1 2021

May 12, 2021
BUY
$83.5 - $98.47 $89,345 - $105,362
1,070 Added 0.57%
190,185 $16.3 Million
Q4 2020

Feb 11, 2021
BUY
$78.07 - $94.43 $5,933 - $7,176
76 Added 0.04%
189,115 $17.9 Million
Q3 2020

Nov 10, 2020
SELL
$82.14 - $91.0 $237,959 - $263,627
-2,897 Reduced 1.51%
189,039 $16.4 Million
Q2 2020

Aug 05, 2020
BUY
$80.93 - $91.1 $307,695 - $346,362
3,802 Added 2.02%
191,936 $16.8 Million
Q1 2020

May 06, 2020
SELL
$70.67 - $99.01 $349,109 - $489,109
-4,940 Reduced 2.56%
188,134 $15.5 Million
Q4 2019

Feb 04, 2020
SELL
$84.35 - $95.37 $506 - $572
-6 Reduced -0.0%
193,074 $18.3 Million
Q3 2019

Nov 06, 2019
SELL
$85.54 - $94.26 $714,601 - $787,448
-8,354 Reduced 4.15%
193,080 $16.8 Million
Q2 2019

Aug 09, 2019
SELL
$75.4 - $92.8 $18,020 - $22,179
-239 Reduced 0.12%
201,434 $18.4 Million
Q1 2019

May 08, 2019
SELL
$75.32 - $86.15 $24,855 - $28,429
-330 Reduced 0.16%
201,673 $19.4 Million
Q4 2018

Jan 31, 2019
SELL
$73.66 - $82.02 $95,389 - $106,215
-1,295 Reduced 0.64%
202,003 $17.3 Million
Q3 2018

Oct 26, 2018
SELL
$66.94 - $77.43 $41,569 - $48,084
-621 Reduced 0.3%
203,298 $17.5 Million
Q2 2018

Aug 02, 2018
SELL
$64.91 - $73.36 $124,821 - $141,071
-1,923 Reduced 0.93%
203,919 $15.4 Million
Q1 2018

May 14, 2018
SELL
$70.39 - $84.15 $10,840 - $12,959
-154 Reduced 0.07%
205,842 $16.6 Million
Q4 2017

Feb 07, 2018
SELL
$72.33 - $77.64 $151,025 - $162,112
-2,088 Reduced 1.0%
205,996 $17.9 Million
Q3 2017

Nov 09, 2017
BUY
$74.14 - $77.27 $15.4 Million - $16.1 Million
208,084
208,084 $17.9 Million

Others Institutions Holding NVS

# of Institutions
1,433
Shares Held
138M
Call Options Held
1.48M
Put Options Held
1.55M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $238B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Edgemoor Investment Advisors, Inc. Portfolio

Follow Edgemoor Investment Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Edgemoor Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Edgemoor Investment Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email